TOKYO: Japan plans to authorise the use of antiviral drug remdesivir to treat coronavirus patients, the government said on Thursday (May 7), with ...
Remdesivir should get the green light in Japan after already receiving approval in the US AFP/Ulrich PerreyTOKYO: Japan plans to authorise the use of antiviral drug remdesivir to treat coronavirus patients, the government said on Thursday , with an eye to approving another medication Avigan this month.
Prime Minister Shinzo Abe said last week the government was getting ready to give a speedy green light to the experimental drug developed by US firm Gilead Sciences. As for Avigan, developed by Japanese firm Fujifilm Toyama Chemical, Suga said the government"aims to approve it this month" if a clinical trial involving 100 patients proves effective.The drug, whose generic name is favipiravir, was approved for use in Japan in 2014 but only in flu outbreaks that are not being effectively addressed by existing medications.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Remdesivir may be approved in Japan on Thursday: Health ministerTOKYO: Gilead Sciences Inc's antiviral drug remdesivir may be approved in Japan for domestic COVID-19 patients when the health ministry's review ...
Read more »
Remdesivir may be approved in Japan on Thursday: Health ministerTOKYO (REUTERS) - Gilead Sciences Inc's antiviral drug remdesivir may be approved in Japan for domestic Covid-19 patients when the health ministry's review board is held on Thursday (May 7), Japanese Health Minister Katsunobu Kato said.. Read more at straitstimes.com.
Read more »
Foreign workers feel the pain of 'corona job cuts' in JapanEight years after arriving from Brazil, Rennan Yamashita sat in a government office in central Japan, filling out forms for unemployment insurance after losing his job for the ninth or 10th time - he has lost count. The coronavirus pandemic has hit Japan's economy hard and many factories, including
Read more »
Remdesivir may be approved in Japan on Thursday: Health ministerTOKYO: Gilead Sciences Inc's antiviral drug remdesivir may be approved in Japan for domestic COVID-19 patients when the health ministry's review ...
Read more »
COVID-19: Gilead in talks to expand global supply of drug remdesivirREUTERS: Gilead Sciences Inc said on Tuesday (May 5) it was in discussions with chemical and drug manufacturers to produce its experimental ...
Read more »
Gilead in talks to expand global supply of Covid-19 drug remdesivirBENGALURU (REUTERS) - Gilead Sciences Inc said on Tuesday (May 5) it was in discussions with chemical and drug manufacturers to produce its experimental Covid-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.. Read more at straitstimes.com.
Read more »